BUCK INSTITUTE FOR RESEARCH ON AGING

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 21234
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7160
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
  
 
C07K PEPTIDES 5131
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
A23K FODDER130
 
  
 
A23L FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT 163
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0000,816 Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related ConditionsAug 11, 17Jan 04, 18[A61K]
2017/0266,211 USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONSJun 01, 17Sep 21, 17[A61K]
2017/0209,435 METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERSMar 23, 17Jul 27, 17[A61K]
2017/0196,857 METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERSMar 10, 17Jul 13, 17[A61K]
2017/0196,858 METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERSMar 10, 17Jul 13, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901080 Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cellsMar 11, 16Feb 27, 18[A61K, C12N, A01K]
9901081 Transgenic mouse for determining the role of senescent cells in cancerMar 25, 16Feb 27, 18[A61K, C12N, A01K, G01N]
9884065 Inhibiting activity of senescent cells using a glucocorticoidMar 22, 16Feb 06, 18[A61K, G01N, A61P]
9855266 Treatment for osteoarthritis by intra-articular administration of a cis-imidazolineMar 23, 17Jan 02, 18[A61K]
9849128 Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cellsMar 10, 17Dec 26, 17[A61K]
9617514 Downregulation of SINE/ALU retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cellOct 20, 11Apr 11, 17[C12N]
9605001 Production of polyketides and other natural productsMar 02, 15Mar 28, 17[C12P, C07D, C12N, C07K]
9534016 Netrin loop peptide mimetics and uses thereofNov 27, 12Jan 03, 17[A61K, C07K]
9382266 Rapamycin analogueDec 21, 12Jul 05, 16[A61K, C07D]
9245290 Caspase inhibitors and uses thereofAug 15, 13Jan 26, 16[C07D, G06Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0359,794 IMPAIRMENT OF THE LARGE RIBOSOMAL SUBUNIT PROTEIN RPL24 BY DEPLETION OR ACETYLATIONAbandonedJun 15, 15Dec 17, 15[A61K]
2015/0209,306 MULTI-COMPONENT FORMULATION FOR IMPROVING NEUROLOGICAL FUNCTIONAbandonedAug 07, 13Jul 30, 15[A61K]
2015/0030,683 FORMULATIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF PRE-MCI AND/OR PRE-ALZHEIMER'S CONDITIONSAbandonedFeb 15, 13Jan 29, 15[A61K]
2014/0371,283 HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSINGAbandonedFeb 12, 14Dec 18, 14[C07D]
2014/0335,074 METHODS FOR IMPROVING MEDICAL THERAPIESAbandonedDec 13, 12Nov 13, 14[A61K, G01N, A61N]
2014/0128,352 COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTIONAbandonedSep 20, 13May 08, 14[A61K, C12Q, G01N]
2013/0288,980 TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4AbandonedMar 14, 13Oct 31, 13[C07K]
2013/0288,981 TARGETING SENESCENT CELLS AND CANCER CELLS BY INTERFERENCE WITH JNK AND/OR FOXO4AbandonedMar 14, 13Oct 31, 13[A61K, A61N]
2013/0017,274 LOW DOSE LITHIUM IN THE TREATMENT OR PROPHYLAXIS OF PARKINSON'S DISEASEAbandonedMar 16, 12Jan 17, 13[A61K, A61P]
2012/0244,567 HUMAN EMBRYONIC STEM CELLS FOR HIGH THROUGHOUT DRUG SCREENINGAbandonedSep 03, 10Sep 27, 12[C12Q, C12N]
2012/0129,834 SEROTONIN RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF HUNTINGTON'S DISEASEAbandonedSep 16, 11May 24, 12[A61K, A61P]
2004/0101,521 Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progressionAbandonedJul 11, 03May 27, 04[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.